Human prostate cancer heterotransplants: A review on this experimental model

Asian Journal of Andrology

Volumn 12, Issue 4, 2010, Pages 509-518

  Lopez Barcons, Lluis A ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; experimental model; heterotransplant; nude mice; prostate; xenotransplant

Indexed keywords

TUMOR MARKER;

CANCER GRAFT; CELL DIFFERENTIATION; DNA CONTENT; HISTOLOGY; HISTOPATHOLOGY; HORMONE DEPENDENCE; IN VITRO STUDY; KINETICS; METASTASIS; MORPHOLOGY; NONHUMAN; PROSTATE CANCER; QUALITY CONTROL; REVIEW; TUMOR BIOPSY; TUMOR CELL CULTURE; TUMOR VASCULARIZATION; ANIMAL; CANCER TRANSPLANTATION; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; VASCULARIZATION; XENOGRAFT;

ANIMALS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77954389136     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.17     Document Type: Review

References (54)

1. De Marzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 1999; 53: 29-39.
2. Taylor RA, Risbridger GP. Prostatic tumor stroma: a key player in cancer progression. Curr Cancer Drug Targets 2008; 8: 490-497
3. Pandita A, Aldape KD, Zadeh G, Guha A, James CD. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplifes EGFR. Genes Chromosomes Cancer 2004; 39: 29-36. (Pubitemid 37475250)
4. De Witt Hamer PC, van Tilborg AA, Eijk PP, Sminia P, Troost D, et al. The genomic profle of human malignant glioma is altered early in primary cell culture and preserved in sphenoids. Oncogene 2008; 27: 2091-2096 (Pubitemid 351442747)
5. Sasai K, Romer JT, Lee Y, Finkelstein D, Fuller C, et al. Shh pathway activity is down-regulated in cultured medul-loblastoma cells: implications for preclinical studies. Cancer Res 2006; 66: 4215-4222
6. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Deve-reux WT, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro.Cancer Res 2009; 69: 3364-3373
7. Whiteford CC, Bilke S, Gree BT, Chen Q, Braunschweig TA, et al. Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res 2007; 67: 32-40. (Pubitemid 46142757)
8. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826 (Pubitemid 32801464)
9. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61: 5974-5978 (Pubitemid 32762523)
10. Glinsky GV, Krones-Herzig A, Glinskii AB, Gebauer G. Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer. Mol Carcinogenesis 2003; 37: 209-221 (Pubitemid 36959537)
11. Lopez-Barcons LA. Serially passaged human prostate cancer heterotransplants as an experimental model. J Cell Mol Med 2009, Oct 29 [Epub ahead of print] PMID: 19874422.
12. Gittes RF, McLaughlin AP, Brooks JD. Discussion of etiology and prevention of prostatic cancer. Cancer Chemother Rep 1975; 59: 73-87.
13. Gittes RF. The nude mouse-its use as tumor-bearing model of the prostate. In: Murphy G P, editor. Models for Prostate Cancer. New York: Alan R. Liss, Inc.; 1980. p31-7.
14. Shimosato Y, Kameya T, Nagai K, Hirohashi S, Koide S, et al. Transplantation of human tumor in nude mice. J Natl Cancer Inst 1976; 56: 1251-1266
15. Williams G, Ghanadian R, Castro JE. The growth and viability of human prostatic tissue maintained in immunosuppressed mice. Clin Oncol 1978; 4: 347-351 (Pubitemid 9105762)
16. Jones MA, Williams G, Davies AJS. Value of xenografts in the investigation of prostatic function: preliminary communication. J Royal Soc Med 1980; 73: 708-712 (Pubitemid 11233502)
17. Reid LM, Minato N, Gresser I, Holland J, Kadish A, et al. Infuence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci USA 1981; 78: 1171-1175 (Pubitemid 11102182)
18. Hoehn W, Schroeder FH, Riemann FJ, Joebsis AC, Hermanek P. Human prostatic adenocarcinoma some characteristic of a serially transplantable line in nude mice PC82. Prostate 1980; 1: 95-104. (Pubitemid 11016689)
19. Graham SD, Poulton SH, Linder J, Woodard MB, Lyles KW, et al. Establishment of a long-term adenocarcinoma of the prostate cell line in the nude mouse. Prostate 1985; 7: 369-376
20. Harper ME, Sibley PEC, Rowlands A, Buttifant L, Beacock C, et al. Hormonal modulation of the growth of a new transplantable prostatic cell line in athymic nude mice. Urol Res 1986; 14: 156.
21. Csapo Z, Brand K, Walther R, Fokas K. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. J Urol 1988; 140: 1032-1038
22. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 1991; 51: 3814-3827
23. Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, et al. Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 1993; 85: 394-408.
24. van Weerden WM, van Kreuningen A, Elissen NMJ, Vermeij M, de Jong FH, et al. Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate 1993; 23: 149-164 (Pubitemid 23289896)
25. de Pinieux G, Legrier LM, Poirson-Bichat F, Courty Y, Bras-Goncalves R, et al. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am J Pathol 2001; 159: 753-764
26. Gray DR, Huss WJ, Yau JM, Durham LE, Werdin ES, et al. Short-term human primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis. Cancer Res 2004; 64: 1712-1721
27. Huss WJ, Gray DR, Werdin ES, Funkhouser Jr WK, Smith GJ. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate 2004; 60: 77-90.
28. McCulloch DR, Opeskin K, Thompson EW, Williams EW. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis. Prostate 2005; 65: 35-43. (Pubitemid 41318829)
29. Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005; 64: 149-159 (Pubitemid 40791764)
30. Schroeder FH, Okada K, Jellinhaus W, Wullstein HK, Heinemeyer HM. Human prostatic adenoma and carcinoma. Transplantation of cultured cells and primary tissue fragments in nude mice. Invest Urol 1976: 13: 395-403.
31. Reid L, Sato G. Development of transplantable tumors of human prostate gland implanted in nude mice. J Cell Biol 1976; 70: 860a.
32. Presnel SC, Werdin ES, Maygarden S, Mohler JL, Smith GJ. Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer. Am J Pathol 2001; 159: 855-870 (Pubitemid 32851006)
33. Lubaroff DM, Cohen MB, Schultz LD, Beamer WG. Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2-activated lymphocytes in scid mice. Prostate 1995; 27: 32-41.
34. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982; 21: 6188-6193
35. Reid LCM, Shin S. Transplantation of heterologus endocrine tumor cells in nude mice. In: Fogh J, Giovanella BC, editors. The Nude Mouse in Experimental and Clinical Research. New York: New York Academic Press; 1978. p313-51.
36. Hoehn W, Wagner M, Riemann JF, Hermanek P, Williams E, et al. Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice. Prostate 1984; 5: 445-452 (Pubitemid 14069312)
37. van Weerden WM, de Ridder CM, Verdaasdonk CL, Ro-mijn JC, van der Kwast TH, et al. Development of seven new human prostate tumor xenografts models and their histopathological characterization. Am J Pathol 1996; 149: 1055-1062
38. Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, et al. Rapid (warm) autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000; 6: 1038-1045 (Pubitemid 30159365)
39. Yoshida T, Kinoshita H, Segawa T, Nakamura E, Inoue T, et al. Antiandrogen bicatulamide promotes tumor growth in a novel androgen-dependent prostate xenograft model derived from a bicatulamide-treated patient. Cancer Res 2005: 65: 9611-9616 (Pubitemid 41541433)
40. van Haaften-Day C, Raghavan D, Russell P, Wills EJ, Gregory P, et al. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. Prostate 1987; 11: 271-279 (Pubitemid 18004765)
41. Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, et al. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res 1996: 2: 1039-1048 (Pubitemid 26198473)
42. Baisch H, Otto U, Fack H. Growth of human prostate carcinomas with and without hormone alpha-dehydro testosterone in nude mice. Eur Urol 1998; 34: 505-511 (Pubitemid 28550315)
43. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997; 3: 402-408 (Pubitemid 27145681)
44. Wakasugi H, Koyama K, Gyotoku M, Yoshimoto M, Hirohashi S, et al. Frequent development of murine T-cell lymphomas with TcR alpha/beta+, CD4-/8-phenotype after implantation of human infammatory breast cancer cells in BALB/c nude mice. Jpn J Cancer Res 1995; 86: 1086-1096 (Pubitemid 3020055)
45. National Cancer Institute Best Practices for Biospecimen Resources (NCI, NIH, Bethesda, Md, 2007); http://biospecimens. cancer.gov/global/pdfs/NCI-Best- Practices-060507.pdf.
46. Lopez-Barcons LA. Human benign prostatic hyperplasia heterotransplants as an experimental model. Asian J Androl 2010; 12: 157-163
47. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edge-house NL, et al. CWR22: the frst human prostate cancer xeno-graft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 1996; 56: 3042-3046 (Pubitemid 26199749)
48. Ito YZ, Nakazato Y. A new serially transplantable human prostatic cancer (Honda) in nude mice. J Urol 1984; 132: 384-387 (Pubitemid 14057583)
49. Buhler KR, Quinn J, Liu AY, Wang H, Ellis WJ, et al. LuCaP 35: an androgen inducible, prostate-specifc antigen producing human prostate cancer xenograft. Proc Am Assoc Cancer Res 1997; 38: 1600.
50. Corey E, Quinn JE, Vessella RL. A novel method of generating prostate cancer metastases from orthotopic implants. Prostate 2003; 56: 110-114 (Pubitemid 41490327)
51. van Steenbrugger GJ, Groen M, Bolt-de Vries J, Romijn JC, Schroeder FH. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth. In: EORTC genitourinary group monograph 2, Part A: therapeutic principles in metastatic prostatic cancer. New York: Alan R. Liss Inc.; 1985. p23-50.
52. Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, et al. The human PC346 xenograft and cell line panel: a model system for prostate cancer progression. Eur Urol 2006; 49: 245-257 (Pubitemid 43197860)
53. Shimosato Y, Kameya T, Nagai T, Hirohashi S, Koide T, et al. Transplantation of human tumors in nude mice. J Natl Cancer Inst 1976; 56: 1251-1260
54. Harper ME, Goddard L, Smith C, Nicholson RI. Characterization of a transplantable hormone-responsive human prostatic cancer xenograft TEN12 and its androgen-resistant sublines. Prostate 2004; 58: 13-22. (Pubitemid 38057984)